Actavis names new senior management team
This article was originally published in Scrip
Executive Summary
Actavis has announced its new senior management team that will lead the company following the close of its acquisition of Allergan, anticipated in the second quarter of 2015. Brent Saunders will continue to lead Actavis as CEO, president and a member of the board of directors. And Paul Bisaro will remain executive chair of the board. Meanwhile the following appoints are planned:
You may also be interested in...
Accessing Venture Debt From The EIB
Tips from Gergely Krajcsi, senior investment officer at the European Investment Bank, on how biotechs can access loans for faster growth.
In Vivo's 2024 Rising Leaders At A Glance
Top 30 leaders: see the list of industry influencers highlighted in the fifth edition of In Vivo's Rising Leaders series.
In Vivo’s 2024 Rising Leaders
The fifth annual listing of In Vivo’s Rising Leaders includes entrepreneurs and innovators from across the world who represent the next wave of creativity in health care.